Results showed that Fibulin-3, as well as tumor size, serum AFP level, tumor multiplicity, clinical stage, vascular invasion, tumor differentiation and relapse, were responsible for the overall and recurrence-free survival of HCC patients (Table 2&3). Here, AFP is linked to hepatocellular carcinoma.